These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

130 related items for PubMed ID: 24827953

  • 1. Isolated central nervous system relapse in a child with non- Hodgkin lymphoma during treatment.
    Kebudi R, Tüysüz G, Doğan Ö, Özdemir N.
    Turk J Pediatr; 2014; 56(1):85-7. PubMed ID: 24827953
    [Abstract] [Full Text] [Related]

  • 2. Intensive chemotherapy without radiotherapy gives more than 85% event-free survival for non-Hodgkin lymphoma without central nervous involvement: a 6-year population-based study from the nordic society of pediatric hematology and oncology.
    Márky I, Björk O, Forestier E, Jónsson OG, Perkkiö M, Schmiegelow K, Storm-Mathiesen I, Gustafsson G, Nordic Society of Pediatric Hematology and Oncology.
    J Pediatr Hematol Oncol; 2004 Sep; 26(9):555-60. PubMed ID: 15342981
    [Abstract] [Full Text] [Related]

  • 3. Prevalence, clinical pattern, and outcome of CNS involvement in childhood and adolescent non-Hodgkin's lymphoma differ by non-Hodgkin's lymphoma subtype: a Berlin-Frankfurt-Munster Group Report.
    Salzburg J, Burkhardt B, Zimmermann M, Wachowski O, Woessmann W, Oschlies I, Klapper W, Wacker HH, Ludwig WD, Niggli F, Mann G, Gadner H, Riehm H, Schrappe M, Reiter A.
    J Clin Oncol; 2007 Sep 01; 25(25):3915-22. PubMed ID: 17761975
    [Abstract] [Full Text] [Related]

  • 4. Characteristics of Central Nervous System (CNS) Involvement in Children With Non-Hodgkin's Lymphoma (NHL) and the Diagnostic Value of CSF Flow Cytometry in CNS Positive Disease.
    Huang S, Jin L, Yang J, Duan Y, Zhang M, Zhou C, Zhang YH.
    Technol Cancer Res Treat; 2021 Sep 01; 20():15330338211016372. PubMed ID: 34060372
    [Abstract] [Full Text] [Related]

  • 5. [Therapeutic management of central nervous system lymphomas in a single hematological institute].
    Iványi JL, Marton E, Plander M, Gyánó G, Czumbil L, Tóth C.
    Orv Hetil; 2009 Oct 18; 150(42):1937-44. PubMed ID: 19812012
    [Abstract] [Full Text] [Related]

  • 6. Very late central nervous system relapse in a patient with B cell lymphoblastic lymphoma.
    Nagasaki A, Miyagi T, Nakazato T, Taira N, Ohshima K, Kikuchi M, Takasu N, Masauda M.
    Acta Haematol; 2004 Oct 18; 112(4):212-6. PubMed ID: 15564734
    [Abstract] [Full Text] [Related]

  • 7. Survival outcome following isolated central nervous system relapse treated with additional chemotherapy and craniospinal irradiation in childhood acute lymphoblastic leukemia.
    Kumar P, Kun LE, Hustu HO, Mulhern RK, Hancock ML, Coffey D, Rivera GK.
    Int J Radiat Oncol Biol Phys; 1995 Feb 01; 31(3):477-83. PubMed ID: 7852109
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Clinical significance of occult cerebrospinal fluid involvement assessed by flow cytometry in non-Hodgkin's lymphoma patients at high risk of central nervous system disease in the rituximab era.
    Sancho JM, Orfao A, Quijano S, García O, Panizo C, Pérez-Ceballos E, Deben G, Salar A, González-Barca E, Alonso N, García-Vela JA, Capote J, Peñalver FJ, Provencio M, Arias J, Plaza J, Caballero D, Morado M, Feliu E, Ribera JM, Spanish Group for the Study of CNS Disease in NHL.
    Eur J Haematol; 2010 Oct 01; 85(4):321-8. PubMed ID: 20528905
    [Abstract] [Full Text] [Related]

  • 10. Impact of cranial radiotherapy on central nervous system prophylaxis in children and adolescents with central nervous system-negative stage III or IV lymphoblastic lymphoma.
    Burkhardt B, Woessmann W, Zimmermann M, Kontny U, Vormoor J, Doerffel W, Mann G, Henze G, Niggli F, Ludwig WD, Janssen D, Riehm H, Schrappe M, Reiter A.
    J Clin Oncol; 2006 Jan 20; 24(3):491-9. PubMed ID: 16421426
    [Abstract] [Full Text] [Related]

  • 11. Prophylactic intrathecal methotrexate and hydrocortisone reduces central nervous system recurrence and improves survival in aggressive non-hodgkin lymphoma.
    Tomita N, Kodama F, Kanamori H, Motomura S, Ishigatsubo Y.
    Cancer; 2002 Aug 01; 95(3):576-80. PubMed ID: 12209750
    [Abstract] [Full Text] [Related]

  • 12. Diagnosis of central nervous system relapse of pediatric acute lymphoblastic leukemia: Impact of routine cytological CSF analysis at the time of intrathecal chemotherapy.
    Gassas A, Krueger J, Alvi S, Sung L, Hitzler J, Lieberman L.
    Pediatr Blood Cancer; 2014 Dec 01; 61(12):2215-7. PubMed ID: 25212396
    [Abstract] [Full Text] [Related]

  • 13. Prevention of CNS recurrence in childhood ALL: results with reduced radiotherapy combined with CNS-directed chemotherapy in four consecutive ALL-BFM trials.
    Schrappe M, Reiter A, Henze G, Niemeyer C, Bode U, Kühl J, Gadner H, Havers W, Plüss H, Kornhuber B, Zintl F, Ritter J, Urban C, Niethammer D, Riehm H.
    Klin Padiatr; 1998 Dec 01; 210(4):192-9. PubMed ID: 9743952
    [Abstract] [Full Text] [Related]

  • 14. Poor outcome for children and adolescents with progressive disease or relapse of lymphoblastic lymphoma: a report from the berlin-frankfurt-muenster group.
    Burkhardt B, Reiter A, Landmann E, Lang P, Lassay L, Dickerhoff R, Lakomek M, Henze G, von Stackelberg A.
    J Clin Oncol; 2009 Jul 10; 27(20):3363-9. PubMed ID: 19433688
    [Abstract] [Full Text] [Related]

  • 15. Management of Non-Hodgkin Lymphoma: ICMR Consensus Document.
    Thacker N, Bakhshi S, Chinnaswamy G, Vora T, Prasad M, Bansal D, Agarwala S, Kapoor G, Radhakrishnan V, Laskar S, Kaur T, Rath GK, Dhaliwal RS, Arora B.
    Indian J Pediatr; 2017 May 10; 84(5):382-392. PubMed ID: 28378140
    [Abstract] [Full Text] [Related]

  • 16. The impact of age and gender on biology, clinical features and treatment outcome of non-Hodgkin lymphoma in childhood and adolescence.
    Burkhardt B, Zimmermann M, Oschlies I, Niggli F, Mann G, Parwaresch R, Riehm H, Schrappe M, Reiter A, BFM Group.
    Br J Haematol; 2005 Oct 10; 131(1):39-49. PubMed ID: 16173961
    [Abstract] [Full Text] [Related]

  • 17. A prospective neurocognitive evaluation of children treated with additional chemotherapy and craniospinal irradiation following isolated central nervous system relapse in acute lymphoblastic leukemia.
    Kumar P, Mulhern RK, Regine WF, Rivera GK, Kun LE.
    Int J Radiat Oncol Biol Phys; 1995 Feb 01; 31(3):561-6. PubMed ID: 7852120
    [Abstract] [Full Text] [Related]

  • 18. Diagnosis and treatment of central nervous system involvement in non-Hodgkin's lymphoma.
    Bierman P, Giglio P.
    Hematol Oncol Clin North Am; 2005 Aug 01; 19(4):597-609, v. PubMed ID: 16083825
    [Abstract] [Full Text] [Related]

  • 19. Isolated central nervous system relapse in aggressive non-Hodgkin's lymphoma: the Bologna experience.
    Zinzani PL, Magagnoli M, Frezza G, Prologo G, Gherlinzoni F, Bendandi M, Albertini P, Babini L, D'Alessandro R, Tura S.
    Leuk Lymphoma; 1999 Feb 01; 32(5-6):571-6. PubMed ID: 10048430
    [Abstract] [Full Text] [Related]

  • 20. Clinical features and early treatment response of central nervous system involvement in childhood acute lymphoblastic leukemia.
    Levinsen M, Taskinen M, Abrahamsson J, Forestier E, Frandsen TL, Harila-Saari A, Heyman M, Jonsson OG, Lähteenmäki PM, Lausen B, Vaitkevičienė G, Asberg A, Schmiegelow K, Nordic Society of Paediatric Haematology and Oncology (NOPHO).
    Pediatr Blood Cancer; 2014 Aug 01; 61(8):1416-21. PubMed ID: 24623619
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.